Literature DB >> 17636573

WITHDRAWN: Interventions for promoting adherence to tuberculosis management.

J Volmink1, P Garner.   

Abstract

BACKGROUND: Up to half the people with tuberculosis do not complete their treatment. Strategies to improve adherence to diagnostic and treatment regimens are therefore important.
OBJECTIVES: To assess the effects of various interventions aimed at promoting adherence to anti-tuberculosis treatment and completion of TB diagnostic protocols. SEARCH STRATEGY: We searched the Cochrane Controlled Trials Register, the Cochrane Infectious Diseases Group trials register, Medline, Embase, Lilacs and reference lists of articles. We contacted experts in the field. SELECTION CRITERIA: Randomised and quasi-randomised trials of interventions to promote adherence with curative or preventive chemotherapy and diagnostic protocols for tuberculosis. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial quality and extracted data. MAIN
RESULTS: Fourteen trials were included. Reminder cards sent to defaulters, a combination package of a monetary incentive and health education and more supervision of clinic staff increased the number of people completing their tuberculosis treatment. Intensive counselling/education did not help in one study. Direct observation showed better clinical outcomes in one study, and no difference in another. Return to the clinic for reading of a tuberculin skin test was enhanced by monetary incentives, assistance by lay health workers, contracts and telephone prompts but not by health education. AUTHORS'
CONCLUSIONS: We have found evidence of benefit for a number of specific interventions to improve adherence to anti-tuberculous therapy and completion of diagnostic protocols. These should be implemented by health care providers where appropriate to local circumstances. Future studies in low income countries are a priority and should measure adherence and clinical outcomes. This review summarises trials up to 2000. It is being replaced by a series of reviews on particular intervention strategies. The details are in the 'Published notes' section.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636573     DOI: 10.1002/14651858.CD000010

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  6 in total

Review 1.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

2.  The Use of Research Evidence in Two International Organizations' Recommendations about Health Systems.

Authors:  Steven J Hoffman; John N Lavis; Sara Bennett
Journal:  Healthc Policy       Date:  2009-08

Review 3.  Directly observed therapy for treating tuberculosis.

Authors:  Jamlick Karumbi; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

4.  Beyond pills and tests: addressing the social determinants of tuberculosis.

Authors:  Tom Wingfield; Marco A Tovar; Doug Huff; Delia Boccia; Matthew J Saunders; Sumona Datta; Rosario Montoya; Eric Ramos; James J Lewis; Robert H Gilman; Carlton Evans
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

5.  Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up.

Authors:  Prahlad Duggal; Malay Sarkar
Journal:  BMC Ear Nose Throat Disord       Date:  2007-11-12

6.  Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives.

Authors:  Geetika Verma; Ross E G Upshur; Elizabeth Rea; Solomon R Benatar
Journal:  BMC Med Ethics       Date:  2004-03-12       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.